GB0506670D0 - Method - Google Patents

Method

Info

Publication number
GB0506670D0
GB0506670D0 GB0506670A GB0506670A GB0506670D0 GB 0506670 D0 GB0506670 D0 GB 0506670D0 GB 0506670 A GB0506670 A GB 0506670A GB 0506670 A GB0506670 A GB 0506670A GB 0506670 D0 GB0506670 D0 GB 0506670D0
Authority
GB
United Kingdom
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0506670A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AstraZeneca AB
Original Assignee
AstraZeneca AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by AstraZeneca AB filed Critical AstraZeneca AB
Priority to GB0506670A priority Critical patent/GB0506670D0/en
Publication of GB0506670D0 publication Critical patent/GB0506670D0/en
Priority to PCT/GB2006/001136 priority patent/WO2006103421A2/en
Priority to TW095111374A priority patent/TW200720440A/en
Ceased legal-status Critical Current

Links

GB0506670A 2005-04-01 2005-04-01 Method Ceased GB0506670D0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
GB0506670A GB0506670D0 (en) 2005-04-01 2005-04-01 Method
PCT/GB2006/001136 WO2006103421A2 (en) 2005-04-01 2006-03-29 Method for predicting the response to receptor tyrosine kinase inhibitors
TW095111374A TW200720440A (en) 2005-04-01 2006-03-31 Method

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0506670A GB0506670D0 (en) 2005-04-01 2005-04-01 Method

Publications (1)

Publication Number Publication Date
GB0506670D0 true GB0506670D0 (en) 2005-05-11

Family

ID=34586567

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0506670A Ceased GB0506670D0 (en) 2005-04-01 2005-04-01 Method

Country Status (3)

Country Link
GB (1) GB0506670D0 (en)
TW (1) TW200720440A (en)
WO (1) WO2006103421A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008088885A2 (en) * 2007-01-18 2008-07-24 Creighton University Epidermal growth factor receptor mutations and methods of use
US9994914B2 (en) 2014-10-09 2018-06-12 Roche Molecular Systems, Inc. Mutation in the epidermal growth factor receptor kinase domain

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005094357A2 (en) * 2004-03-31 2005-10-13 The General Hospital Corporation Method to determine responsiveness of cancer to epidermal growth factor receptor targeting treatments
EP1766068A4 (en) * 2004-06-04 2010-03-03 Genentech Inc Egfr mutations
TW200617396A (en) * 2004-10-06 2006-06-01 Astrazeneca Ab Method

Also Published As

Publication number Publication date
TW200720440A (en) 2007-06-01
WO2006103421A2 (en) 2006-10-05
WO2006103421A3 (en) 2007-03-22

Similar Documents

Publication Publication Date Title
EP1864785A4 (en) Seterolithography method
GB0504774D0 (en) Method
GB0503836D0 (en) Method
GB0512214D0 (en) Method
GB0519303D0 (en) Chemo-immunotherapy method
GB0520375D0 (en) Method
GB0509433D0 (en) Method
GB0504096D0 (en) Method
GB0507123D0 (en) Method
GB0504184D0 (en) Method
GB0520235D0 (en) Method
GB0510536D0 (en) Method
GB0508420D0 (en) Method
GB0505756D0 (en) Method
GB0502046D0 (en) Method
GB0509305D0 (en) Method
GB0515695D0 (en) Method
GB0509437D0 (en) Method
GB0520981D0 (en) Method
GB0518667D0 (en) Method
GB0504182D0 (en) Method
GB0509956D0 (en) Method
GB0506670D0 (en) Method
GB0502360D0 (en) Method
GB0520325D0 (en) Method

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)